Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Quetiapine monotherapy in adolescents with bipolar disorder comorbid with conduct disorder.

Masi G, Pisano S, Pfanner C, Milone A, Manfredi A.

J Child Adolesc Psychopharmacol. 2013 Oct;23(8):568-71. doi: 10.1089/cap.2013.0063.

2.
3.

Quetiapine addition in methylphenidate treatment-resistant adolescents with comorbid ADHD, conduct/oppositional-defiant disorder, and aggression: a prospective, open-label study.

Kronenberger WG, Giauque AL, Lafata DE, Bohnstedt BN, Maxey LE, Dunn DW.

J Child Adolesc Psychopharmacol. 2007 Jun;17(3):334-47.

PMID:
17630867
4.

Bipolar co-morbidity in pediatric obsessive-compulsive disorder: clinical and treatment implications.

Masi G, Perugi G, Millepiedi S, Toni C, Mucci M, Pfanner C, Berloffa S, Pari C, Akiskal HS.

J Child Adolesc Psychopharmacol. 2007 Aug;17(4):475-86.

PMID:
17822342
5.

Effectiveness of lithium in children and adolescents with conduct disorder: a retrospective naturalistic study.

Masi G, Milone A, Manfredi A, Pari C, Paziente A, Millepiedi S.

CNS Drugs. 2009;23(1):59-69. doi: 10.2165/0023210-200923010-00004.

PMID:
19062775
6.

Attention-deficit hyperactivity disorder -- bipolar comorbidity in children and adolescents.

Masi G, Perugi G, Toni C, Millepiedi S, Mucci M, Bertini N, Pfanner C.

Bipolar Disord. 2006 Aug;8(4):373-81.

PMID:
16879138
7.

Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.

Cutler AJ, Datto C, Nordenhem A, Minkwitz M, Acevedo L, Darko D.

Clin Ther. 2011 Nov;33(11):1643-58. doi: 10.1016/j.clinthera.2011.10.002. Epub 2011 Nov 4.

PMID:
22054797
8.

Efficacy and Safety of Risperidone and Quetiapine in Adolescents With Bipolar II Disorder Comorbid With Conduct Disorder.

Masi G, Milone A, Stawinoga A, Veltri S, Pisano S.

J Clin Psychopharmacol. 2015 Oct;35(5):587-90. doi: 10.1097/JCP.0000000000000371.

PMID:
26226481
9.

Quetiapine adjunctive and monotherapy for pediatric bipolar disorder: a retrospective chart review.

Marchand WR, Wirth L, Simon C.

J Child Adolesc Psychopharmacol. 2004 Fall;14(3):405-11.

PMID:
15650496
10.

Randomized controlled pilot study of quetiapine in the treatment of adolescent conduct disorder.

Connor DF, McLaughlin TJ, Jeffers-Terry M.

J Child Adolesc Psychopharmacol. 2008 Apr;18(2):140-56. doi: 10.1089/cap.2006.0007.

PMID:
18439112
11.

Safety, tolerability, and efficacy of quetiapine in youth with schizophrenia or bipolar I disorder: a 26-week, open-label, continuation study.

Findling RL, Pathak S, Earley WR, Liu S, DelBello M.

J Child Adolesc Psychopharmacol. 2013 Sep;23(7):490-501. doi: 10.1089/cap.2012.0092. Epub 2013 Sep 11.

12.
13.

Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial.

Tramontina S, Zeni CP, Ketzer CR, Pheula GF, Narvaez J, Rohde LA.

J Clin Psychiatry. 2009 Apr 21;70(5):756-64. doi: 10.4088/JCP.08m04726.

PMID:
19389329
14.

A 26-week open-label study of quetiapine in children with conduct disorder.

Findling RL, Reed MD, O'Riordan MA, Demeter CA, Stansbrey RJ, McNamara NK.

J Child Adolesc Psychopharmacol. 2007 Feb;17(1):1-9.

PMID:
17343549
15.

A 12-week single-blind trial of quetiapine for the treatment of mood symptoms in adolescents at high risk for developing bipolar I disorder.

DelBello MP, Adler CM, Whitsel RM, Stanford KE, Strakowski SM.

J Clin Psychiatry. 2007 May;68(5):789-95.

PMID:
17503991
16.

Predictors of nonresponse to psychosocial treatment in children and adolescents with disruptive behavior disorders.

Masi G, Manfredi A, Milone A, Muratori P, Polidori L, Ruglioni L, Muratori F.

J Child Adolesc Psychopharmacol. 2011 Feb;21(1):51-5. doi: 10.1089/cap.2010.0039.

PMID:
21309697
17.

A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.

DelBello MP, Chang K, Welge JA, Adler CM, Rana M, Howe M, Bryan H, Vogel D, Sampang S, Delgado SV, Sorter M, Strakowski SM.

Bipolar Disord. 2009 Aug;11(5):483-93. doi: 10.1111/j.1399-5618.2009.00728.x.

PMID:
19624387
18.

Externalizing disorders in consecutively referred children and adolescents with bipolar disorder.

Masi G, Toni C, Perugi G, Travierso MC, Millepiedi S, Mucci M, Akiskal HS.

Compr Psychiatry. 2003 May-Jun;44(3):184-9.

PMID:
12764705
19.

Olanzapine treatment in adolescents with severe conduct disorder.

Masi G, Milone A, Canepa G, Millepiedi S, Mucci M, Muratori F.

Eur Psychiatry. 2006 Jan;21(1):51-7.

PMID:
16487906
20.

Effect of OROS methylphenidate on encopresis in children with attention-deficit/hyperactivity disorder.

Yılmaz S, Bilgiç A, Hergüner S.

J Child Adolesc Psychopharmacol. 2014 Apr;24(3):158-60. doi: 10.1089/cap.2013.0023. Epub 2013 Oct 29.

PMID:
24168715

Supplemental Content

Support Center